Stay updated on SAGE-217 in Essential Tremor Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 in Essential Tremor Clinical Trial page.

Latest updates to the SAGE-217 in Essential Tremor Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe clinical-trial page now displays the study record for SAGE-217 in participants with essential tremor, including study details, results measures, participating locations, and linked study documents.SummaryDifference73%

- Check18 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0 while the study page remains inaccessible behind a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces NIH’s transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check32 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now displays a 403 Forbidden error for the study record, replacing the usual study details with an error page.SummaryDifference20%

Stay in the know with updates to SAGE-217 in Essential Tremor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 in Essential Tremor Clinical Trial page.